|Bid||246.35 x 100|
|Ask||254.70 x 100|
|Day's Range||252.00 - 254.45|
|52 Week Range||223.02 - 333.65|
|PE Ratio (TTM)||15.84|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Biogen, the state’s largest local drug company by market cap and headcount, is about to lose yet another top executive. Kenneth DiPietro plans to step down as executive vice president of human resources ...
Biogen Inc. (BIIB) announced that the conditional marketing authorization for its drug Fampyra for improvement of walking in multiple sclerosis (MS) patients in the EU has been converted to a standard marketing approval.